Campbell & Co Investment Adviser’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Campbell & Co Investment Adviser’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-35,824	Closed	-$595K	–	614
2019 Q4	$595K	Buy	35,824 +11,893	+50%	+$193K	0.18%	178
2019 Q3	$398K	Sell	23,931 -1,010	-4%	-$14K	0.15%	263
2019 Q2	$343K	Buy	24,941 +3,255	+15%	+$49.8K	0.16%	260
2019 Q1	$374K	Sell	21,686 -1,884	-8%	-$29.8K	0.18%	205
2018 Q4	$334K	Sell	23,570 -3,830	-14%	-$58.1K	0.33%	125
2018 Q3	$445K	Buy	+27,400	New	+$392K	0.3%	98

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Campbell & Co Investment Adviser's OXFD Position: Q1 2020 in Review

Campbell & Co Investment Adviser sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2020, closing a stake of 35,824 shares — an estimated $595K sold.

Campbell & Co Investment Adviser first reported a position in OXFD in Q3 2018 and held it in 6 quarters. The position peaked at $595K in Q4 2019. 65 funds tracked by Wall St. Rank hold OXFD as of Q1 2020.

Campbell & Co Investment Adviser reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Campbell & Co Investment Adviser sold 35,824 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2020, an estimated $595K.
Campbell & Co Investment Adviser first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2018 and held it in 6 quarters.
Campbell & Co Investment Adviser's Oxford Immunotec Global PLC Ordinary Shares position peaked at $595K in Q4 2019.
65 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2020.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2020, filed 29 Apr 2020.